Goodreid Blog

CURA And The U.S. Senate

January 06, 2021

Curaleaf Holdings Inc. (CURA) is an American cannabis company listed on the Canadian Securities Exchange. CURA has rallied nicely over the past 3 months in lockstep with political developments in the U.S.. Shares picked up strong momentum when Joe Biden won the Presidency in November and gains continued as the U.S. Senate polls turned to favour the Democratic Party in Georgia.  Today as this blog is written, the stock continues to strengthen on the likelihood that the Democratic Party will win both of Georgia’s Senate seats and will control the White House, Senate, and House, and thus have a good path to enacting legislation.

The enthusiasm for the shares reflects the widely held view that a Democrat controlled government will enact the SAFE Banking Act quickly, most likely by mid 2021.  There is believed to be sufficient Republican support for the bill to block a filibuster.  The bill was passed by the House by a wide margin in 2019, but was then blocked by the Republican Senate.  Currently multi-state operators like CURA are precluded from doing business with federally chartered banks (i.e. Citi, JP Morgan, Wells Fargo, Bank of America, etc.) and have to resort to banking with credit unions and small regional banks.  Cannabis companies accordingly have had a very high cost of capital (debt capital, at least) and CURA itself was in the marketplace last January with a new 13% $300m term loan facility…obviously exorbitant relative to corporate lending rates offered by mainstream banks.  Moreover, dispensaries cannot currently transact via debit card or credit card, as cannabis is federally illegal.  As you might imagine, this causes a lot of problems in terms of handling cash, security/theft/robbery, etc., not to mention the fact that people in the current environment seem to prefer contactless payment methods.  

Perhaps most notably, under current legislation, cannabis companies cannot deduct many normal operating expenditure items in computing taxable income, because although the activity itself is illegal federally, the proceeds of cannabis sales are nevertheless taxable in the eyes of the IRS, but the business expenses related to the proceeds from an illegal activity are not deductible in computing taxable income.  The result is that the handful of them that are currently profitable oftentimes end up paying effective tax rates in excess of 100%, absent some very creative maneuvering by their accountants.  For this reason, cannabis companies look very expensive on the surface, but less so when you normalize the tax rates they currently pay.

Passage of the SAFE Banking Act would rectify all of these problems, and although it would stop short of full federal legalization of cannabis, it would nevertheless be a huge win for CURA and other cannabis operators in the States.


Brian Madden

Senior Vice President, Portfolio Manager

Brian began his investment career in 1997 with one of Canada’s foremost independent research firms.

See Biography

Other Posts

The Financial Post: These tax-loss selling targets are also table-pounding buys

23 November, 2023

As we approach year-end, many investors are turning their attention to tax-loss selling, the strategy of selling investments that have experienced a loss in order to offset capital gains and potentially reduce an investor’s tax liability.

Read More

The Financial Post: Banks are taking it on the chin, but here’s why they deserve a second look

26 October, 2023

Canadian banks have long been considered a solid investment choice for a variety of reasons, but perhaps the best thing they have going for them is the oligopolistic nature of the industry. The Big Six — namely Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank…

Read More

The Financial Post: Just as in baseball, investors can do better by waiting for the perfect pitch

28 September, 2023

Major League Baseball playoffs have arrived, and the best teams will duel it out to be crowned world champions for another year. While history will undoubtedly be made, with exciting walk-offs and bitter disappointments on tap, one thing is and has always been true: hitting a baseball…

Read More

The Globe and Mail: Dividend investing works wonders - and now’s a great time to start with these three stocks

29 August, 2023

When it comes to investing in a diversified portfolio of Canadian equities, there are usually two choices: a total return Canadian equity portfolio, or a Canadian equity dividend portfolio that generates considerably higher income.

Read More

The Globe and Mail: Why this money manager thinks Canada is the best place to invest over the U.S. right now

12 May, 2023

While many investors look around the world for the best places to invest, money manager Robert Gill believes some of the best bets are at home in Canada, especially now. Mr. Gill, senior vice president and Canadian portfolio manager at Goodreid Investment Counsel Corp. in Toronto,…

Read More

The Globe and Mail: What is Topicus and why it’s a stock pick among our Investing Club members

03 May, 2023

Years ago I was fortunate enough to be invited to Omaha, Neb., to have lunch with Warren Buffett. As Warren sat down beside me at Gorat’s, his favourite steakhouse, I was bursting with questions. After a brief introduction, I asked, “What advice would you offer a young person starting…

Read More